Increased sales were primarily driven by growth from key disruptive products, including the minimally invasive surgical and lateral platform products.

"I am extremely pleased with our second quarter results," said David Paul, chairman and CEO of Globus Medical. "We continue to grow well in excess of the industry averages by introducing better solutions for our customers and patients. In addition, we have maintained our focus on efficient operations and healthy cash flow."

More Articles on Orthopedic Devices:

Bonovo Orthopedics Launches PEEK Lateral Interbody Fusion Cage in China

6 Things to Know About the Spine Market

Medtronic Spine Revenue Drops 5% This Quarter